The novel treatment of the medication represents a major development in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets dual pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatide-peptide108560.blogsuperapp.com/42567340/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment